Compare Cadence Design Systems Inc (CDNS) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cadence Design Systems Inc vs Inovio Pharmaceuticals Inc — how do they compare? Cadence Design Systems Inc trades at $326.51 (market cap $90.20B), while Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M). The key difference: Cadence Design Systems Inc is far larger — about 1148.3× Inovio Pharmaceuticals Inc's market cap, and Cadence Design Systems Inc is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CDNS | INO | |
|---|---|---|
Market Cap | $90.20B | $78.55M |
Sector | Technology | Health |
52-Week High | $416.39 | $2.87 |
52-Week Low | $265.66 | $0.66 |
Enterprise Value | $91.41B | $49.56M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cadence Design Systems Inc
Cadence Design Systems is a provider of electronic design automation software, intellectual property, and system design and analysis products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Cadence offers a portfolio of design IP, as well as system design and analysis products, which enable system-level analysis and verification solutions. Cadence's comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers, alongside secular digitalization of various end markets, benefits EDA vendors like Cadence.
Read more on CDNS →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
